Future work to elucidate mechanisms of altered expression and function for MPC1, MPC2, and PDK isoforms and their adaptations in heart failure progression will be valuable in the setting of mitochondrial energy regulation and the development of clinically viable novel drugs for these targets. The gene discussed is MPC2; the disease is heart failure.